Core Viewpoint - Wix.com has recently gained attention as one of the most searched stocks, prompting analysis of factors influencing its future stock performance [1] Earnings Estimate Revisions - Wix.com is expected to report earnings of $1.79 per share for the current quarter, reflecting a year-over-year increase of +7.2%, although the Zacks Consensus Estimate has decreased by -5.2% over the last 30 days [5] - For the current fiscal year, the consensus earnings estimate is $7.27, indicating a +13.8% change from the previous year, with a recent downward revision of -6.4% [5] - The next fiscal year's consensus earnings estimate stands at $8.68, suggesting a +19.4% increase compared to the prior year, with a slight decrease of -1.8% in the last month [6] - Wix.com holds a Zacks Rank 3 (Hold), indicating a neutral outlook based on recent changes in earnings estimates and other related factors [7] Revenue Growth Forecast - The consensus sales estimate for Wix.com is $487.58 million for the current quarter, representing a year-over-year growth of +11.9% [11] - For the current fiscal year, revenue estimates are $1.98 billion, indicating a +12.7% change, while the next fiscal year's estimate is $2.22 billion, reflecting a +12.1% increase [11] Last Reported Results and Surprise History - In the last reported quarter, Wix.com achieved revenues of $473.65 million, a +12.8% increase year-over-year, with an EPS of $1.55 compared to $1.29 a year ago [12] - The reported revenues exceeded the Zacks Consensus Estimate of $471.78 million by +0.4%, although the EPS fell short by -6.63% [12] - Over the past four quarters, Wix.com has surpassed consensus EPS estimates three times and revenue estimates three times [13] Valuation - Wix.com is currently graded D in the Zacks Value Style Score, indicating it is trading at a premium compared to its peers [17] - Valuation multiples such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF) are essential for assessing whether the stock is overvalued, fairly valued, or undervalued [15][16]

CANADA - 2025/02/10: In this photo illustration, the Lam Research Corporation logo is seen displayed ... More on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty Images Lam Research (NASDAQ:LRCX) stock has experienced a notable increase this year, rising by 22% and significantly outperforming the S&P 500’s modest gain of 2%. This remarkable performance can be attributed primarily to the company’s solid quarterly results, fue ...

He also flagged that the stock's valuation is elevated, with shares currently trading at 25.1x 2025 earnings. Margin expansion potential looks limited, Luyckx added: "Valuation is near historical peaks, and margin expansion from general and administrative leverage in the near term looks limited." His revised $260 price target corresponds to a more conservative 22.1x P/E multiple. The downgrade comes as McDonald's faces a challenging consumer environment, particularly in its core U.S. market, where high pric ...

Company Overview - Brinker International operates restaurant chains including Chili's Grill & Bar and Maggiano's Little Italy, and has recently gained attention from investors [1][2] Stock Performance - Over the past month, Brinker International's shares have returned +25.3%, significantly outperforming the Zacks S&P 500 composite's +7.2% and the Zacks Retail - Restaurants industry's +2.7% [2] Earnings Estimates - The expected earnings for the current quarter are $2.36 per share, reflecting a year-over-year increase of +46.6%. The consensus estimate for the current fiscal year is $8.76, indicating a +113.7% change [5][6] - For the next fiscal year, the consensus earnings estimate is $9.57, representing a +9.2% change from the previous year [6] Revenue Growth - The consensus sales estimate for the current quarter is $1.4 billion, showing a year-over-year change of +15.7%. For the current and next fiscal years, sales estimates are $5.34 billion and $5.51 billion, indicating +20.9% and +3.2% changes, respectively [10] Recent Results - In the last reported quarter, Brinker International achieved revenues of $1.43 billion, a +27.2% year-over-year increase, and an EPS of $2.66 compared to $1.24 a year ago. The revenue exceeded the Zacks Consensus Estimate by +3.35% [11][12] Valuation - Brinker International is graded B in the Zacks Value Style Score, suggesting it is trading at a discount compared to its peers [16]

Core Insights - Hologic (HOLX) has seen a significant share price increase of 13.3% over the past month, outperforming both the industry and broader Medical sector gains of 2.4% and 3.4% respectively, with current prices 23.9% above the 52-week low of $51.90, partly due to the rejection of a private takeover bid from TPG and Blackstone valued at up to $16.7 billion [1][6][9] Performance Comparison - Hologic has outperformed key competitors Exact Sciences (EXAS) and Becton, Dickinson and Company (BDX) during the same timeframe [2] Financial Performance - Following the release of fiscal 2025 second-quarter earnings, Hologic met adjusted EPS expectations but revised its annual outlook due to tariff impacts from China and Costa Rica, funding cuts affecting the Africa business, and a soft capital equipment market [4] Acquisition Interest - The rejected buyout offer from TPG and Blackstone would have valued Hologic's shares between $70 and $72, indicating strong confidence in the company's growth potential [6][7] Clinical Advancements - New data presented at the 2025 American Society of Clinical Oncology Annual Meeting highlighted the significant clinical impact of the Breast Cancer Index (BCI) test, which has been a key growth driver in Hologic's molecular diagnostics business [10][11] Valuation Metrics - Hologic's stock is trading at a price-to-sales (P/S) ratio of 3.40X, below its five-year median of 4.33X and the industry average of 4.16X, indicating an attractive valuation [12][14] Long-Term Growth Prospects - The molecular diagnostics segment is expected to remain a principal revenue driver, with ongoing efforts to expand in the U.S. vaginitis market and a strong pipeline of innovations such as the Envision Mammography Platform [15][16] Analyst Price Target - The average price target for Hologic shares is $68.13, suggesting a potential upside of 8.02% from the recent closing price [17]

Core Viewpoint - PVH's stock has dropped nearly 20% after lowering its full-year guidance despite exceeding Q1 expectations, raising questions about potential investment opportunities in the premium retailer's stock [1][3]. Group 1: Company Overview - PVH, formerly known as Phillips-Van Heusen Corporation, operates iconic fashion brands like Tommy Hilfiger and Calvin Klein, specializing in a wide range of apparel and accessories sold globally [2]. - The company has consistently surpassed earnings expectations, achieving a Q1 EPS of $2.30, exceeding the expected $2.24, although this represents a 6% decline from the previous year's $2.45 [5][6]. Group 2: Financial Performance - PVH reported Q1 sales of $1.98 billion, surpassing estimates of $1.93 billion and showing an increase from $1.95 billion in the prior period [6]. - The company has maintained an average earnings surprise of 13.47% and a sales surprise of 1.38% over the last four quarters [6]. Group 3: Guidance and Projections - PVH has lowered its EPS guidance for fiscal 2026 to between $10.75 and $11.00, down from a previous range of $12.40 to $12.75, and below the current Zacks Consensus of $12.59 [8][9]. - Despite the lowered guidance, Zacks projects a 13% increase in annual earnings for FY27 to $14.21, although EPS estimates may trend lower following the recent guidance [9]. Group 4: Valuation Metrics - PVH's stock is currently valued at 6.4X forward earnings, significantly lower than the Zacks Textile-Apparel Industry average of 13.3X, indicating a potential buying opportunity for long-term investors [11]. - The company's PEG ratio stands at 0.57, suggesting it is undervalued relative to its growth rate, and it trades at less than 1X forward sales [12]. Group 5: Investment Considerations - Following the Q1 report, PVH stock holds a Zacks Rank 3 (Hold), with potential for a rebound, but investors should monitor earnings estimate revisions closely [16]. - A decline in FY26 EPS estimates is anticipated, and a significant drop in FY27 estimates could indicate further downside risk [16][17].

Group 1 - Costco's shares fell by 3.9% after reporting May comparable sales that were slightly below estimates [1][4] - In May, Costco's comparable sales increased by 4.3%, or 6% when adjusted for fuel prices and foreign exchange, which was lower than the growth rate of 5.8% for the first 39 weeks of the fiscal year [4] - Overall revenue for the four-week period ending June 1 rose by 6.8%, but this was just below the expected adjusted comparable-sales growth of 6.2% [4][5] Group 2 - Wells Fargo noted that despite the slight miss in sales, Costco continues to perform well but has a high valuation, maintaining an equal weight rating with a price target of $1,000 [5] - Costco's current price-to-earnings ratio is 57, indicating high expectations are already factored into the stock price [7] - The market's reaction to a moderation in growth rates suggests that any further disappointing numbers could lead to additional declines in the stock price [6][7]

Core Insights - BJ's Restaurants, Inc. (BJRI) shares have increased by 20.6% over the past month, outperforming the industry and the S&P 500, which grew by 1.9% and 6.3% respectively [2] - The stock closed at $44.94, nearing its 52-week high of $45.80 and significantly above its 52-week low of $27.61 [2] - Comparable sales rose by 1.7% in Q1, supported by strong traffic and operational upgrades that enhanced guest satisfaction [7][11] Performance Metrics - BJRI's stock is trading above its 50-day moving average, indicating strong upward momentum and price stability [5] - Earnings estimates for 2025 have increased by 6.6% in the last 30 days, with projected EPS growth of 21.9% and revenue growth of 3.1% [7][16] - BJRI's forward 12-month price-to-earnings ratio is 22.93, which is lower than the industry average, suggesting it is currently valued at a discount [18] Operational Initiatives - The company is focusing on sales-building initiatives, productivity, and cost savings to enhance shareholder value [10] - BJRI has implemented measures to improve dining room and kitchen operations, which have positively impacted guest satisfaction scores [13] - The company has completed eight remodels in 2025 and plans to update approximately 20 additional locations by year-end, with remodeled restaurants performing better than non-remodeled units [14] Market Position - BJRI is benefiting from a balanced approach to expansion while optimizing its restaurant portfolio for maximum shareholder returns [15] - Compared to competitors like Wendy's, First Watch Restaurant, and Jack in the Box, BJRI is expected to see earnings growth while its peers are projected to experience declines [16]

Core Viewpoint - Bank of America (BAC) has been trending recently, with its stock performance influenced by earnings estimates and revenue growth projections [1][2]. Earnings Estimate Revisions - For the current quarter, Bank of America is expected to report earnings of $0.90 per share, reflecting an increase of +8.4% year-over-year, with a consensus estimate change of +0.3% over the last 30 days [5]. - The consensus earnings estimate for the current fiscal year stands at $3.68, indicating a year-over-year change of +12.2%, with a +0.4% change over the last month [5]. - For the next fiscal year, the consensus earnings estimate is $4.24, representing a +15.3% change from the previous year, with no change in the estimate over the past month [6]. - The Zacks Rank for Bank of America is 3 (Hold), indicating a neutral outlook based on recent earnings estimate revisions [7]. Projected Revenue Growth - The consensus sales estimate for the current quarter is $26.72 billion, showing a year-over-year increase of +5.3% [11]. - For the current fiscal year, the revenue estimates are $107.99 billion, and for the next fiscal year, $114.07 billion, indicating changes of +6% and +5.6%, respectively [11]. Last Reported Results and Surprise History - In the last reported quarter, Bank of America achieved revenues of $27.37 billion, a +6% increase year-over-year, with an EPS of $0.90 compared to $0.83 a year ago [12]. - The company exceeded the Zacks Consensus Estimate for revenues by +1.89% and for EPS by +11.11% [12]. - Bank of America has consistently beaten consensus EPS and revenue estimates in the last four quarters [13]. Valuation - Bank of America is graded F in the Zacks Value Style Score, indicating it is trading at a premium compared to its peers [17].

Factors Influencing Newmont's Stock Movements in Recent Months Newmont (NYSE:NEM)'s stock has experienced quite a bit of volatility this year. It began the year on a weak note, primarily impacted by declining gold prices and concerns regarding costs and production delays. However, things started to improve as gold prices surged—thanks to global uncertainty and increased purchases by central banks. Thus far in 2025, NEM has made a solid recovery, regaining a significant portion of its previous losses. Althou ...